Atlassian (NASDAQ:TEAM) Research Coverage Started at Guggenheim

Guggenheim began coverage on shares of Atlassian (NASDAQ:TEAM) in a research report released on Thursday, Marketbeat Ratings reports. The firm issued a buy rating and a $225.00 target price on the technology company’s stock.

TEAM has been the subject of a number of other reports. UBS Group reiterated a “hold” rating on shares of Atlassian in a research note on Monday, July 7th. Truist Financial set a $230.00 price target on Atlassian in a research note on Friday, August 8th. Stephens decreased their price target on Atlassian from $221.00 to $202.00 and set an “equal weight” rating for the company in a research note on Monday, August 11th. Raymond James Financial decreased their price target on Atlassian from $300.00 to $250.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. Finally, Cantor Fitzgerald decreased their price target on Atlassian from $256.00 to $240.00 and set an “overweight” rating for the company in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Atlassian presently has an average rating of “Moderate Buy” and a consensus target price of $255.45.

Atlassian Trading Down 1.0%

Shares of NASDAQ TEAM opened at $174.87 on Thursday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.22 and a quick ratio of 1.22. The stock has a market capitalization of $45.87 billion, a P/E ratio of -176.63 and a beta of 0.95. Atlassian has a 1-year low of $154.07 and a 1-year high of $326.00. The business has a fifty day moving average price of $182.36 and a 200 day moving average price of $203.57.

Atlassian (NASDAQ:TEAM) last issued its quarterly earnings data on Thursday, August 7th. The technology company reported $0.98 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.15. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Atlassian had a negative return on equity of 14.77% and a negative net margin of 4.92%.The firm’s quarterly revenue was up 22.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.66 EPS. Atlassian has set its Q1 2026 guidance at EPS. FY 2026 guidance at EPS. Equities research analysts expect that Atlassian will post -0.34 EPS for the current fiscal year.

Insider Activity

In related news, CEO Michael Cannon-Brookes sold 7,665 shares of the firm’s stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $175.76, for a total transaction of $1,347,200.40. Following the sale, the chief executive officer directly owned 99,645 shares of the company’s stock, valued at $17,513,605.20. This trade represents a 7.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Scott Farquhar sold 7,665 shares of the firm’s stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $175.76, for a total value of $1,347,200.40. Following the sale, the director directly owned 99,645 shares in the company, valued at approximately $17,513,605.20. This trade represents a 7.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 536,278 shares of company stock worth $100,612,557. 38.55% of the stock is owned by corporate insiders.

Institutional Trading of Atlassian

Several institutional investors have recently bought and sold shares of TEAM. Clean Yield Group grew its holdings in Atlassian by 372.0% in the first quarter. Clean Yield Group now owns 118 shares of the technology company’s stock valued at $25,000 after purchasing an additional 93 shares during the period. Capco Asset Management LLC acquired a new stake in Atlassian in the second quarter valued at approximately $25,000. Smithfield Trust Co grew its holdings in Atlassian by 90.7% in the first quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock valued at $34,000 after purchasing an additional 78 shares during the period. Geneos Wealth Management Inc. lifted its position in shares of Atlassian by 447.2% in the first quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock valued at $42,000 after acquiring an additional 161 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its position in shares of Atlassian by 82.7% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 243 shares of the technology company’s stock valued at $52,000 after acquiring an additional 110 shares in the last quarter. 94.45% of the stock is owned by institutional investors and hedge funds.

Atlassian Company Profile

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.